Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
topical drug delivery
Pharma
Incyte's Opzelura scores in hidradenitis suppurativa study
The company presented positive data from a phase 2 study in mild-to-moderate hidradenitis suppurativa at the AAD's annual meeting on Sunday.
Zoey Becker
Mar 11, 2024 1:58pm
Arcutis' Zoryve has snagged a 2nd dermatology nod from FDA
Dec 15, 2023 7:09pm
Leo unveils detailed results on JAK cream win in hand eczema
Oct 13, 2023 11:05am
Incyte's Opzelura hits goal in eczema trial in young kids
Jul 12, 2023 10:30am
Arcutis' topical cream goes 2 for 2 in pivotal eczema trials
Dec 13, 2022 7:55am
Dermavant launches first streaming commercial for Vtama
Nov 29, 2022 3:20pm
